Is modulation of immune checkpoints on glioblastoma-infiltrating myeloid cells a viable therapeutic strategy? Du R, Zhang J, Lukas RV, Tripathi S, et al. Neuro Oncol 2024 Oct 19:noae193. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Du R, Zhang J, Lukas RV, Tripathi S, et al. Is modulation of immune checkpoints on glioblastoma-infiltrating myeloid cells a viable therapeutic strategy? Neuro Oncol 2024 Oct 19:noae193. doi: 10.1093.
PMID: 39427326